Medscape Conference Coverage, based on selected sessions at the:

American Academy of Addiction Psychiatry (AAAP) 19th Annual Meeting and Symposium

December 04 - 07, 2008; Boca Raton, Florida

This activity is not sanctioned by, nor a part of, the American Academy of Addiction Psychiatry. Conference news does not receive grant support and is produced independently.

Conference News

  • Cattle Steroid Misuse Appears Common

    Misusing cattle steroids to "bulk up" appears to be a common practice, especially among bodybuilders, and the kits required to convert the pellets for cattle to an injectable form usable to humans are readily available, a study reports.
    Medscape Medical News, December 16, 2008
  • Progesterone May Diminish Cocaine Craving

    In a laboratory study of cocaine users, progesterone reduced craving and the feeling of being stimulated by cocaine, researchers report.
    Medscape Medical News, December 12, 2008
  • US College Students Abuse Stimulants

    College students in the United States report abusing stimulants more than opioids, and a "startling number" use intravenous injection as a mode of opioid delivery, new research suggests.
    Medscape Medical News, December 12, 2008
  • AAAP 2008: Heroin-Assisted Treatment Useful as Last-Resort Option

    Heroin-assisted maintenance treatment may be effective for patients with chronic, refractory heroin addiction, researchers say.
    Medscape Medical News, December 10, 2008
  • AAAP 2008: NESARC Findings Changing Understanding of Alcoholism

    New findings from 2 waves of the National Epidemiological Study on Alcohol and Related Conditions are changing clinicians' understanding of alcohol dependence, researchers say.
    Medscape Medical News, December 9, 2008
  • COMT Inhibitor Shows Promise in Treating Marijuana Addiction

    The catechol-o-methyl-transferase inhibitor entacapone shows promise in the treatment of marijuana dependence, a pilot study suggests.
    Medscape Medical News, December 8, 2008
Disclaimer

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the American Academy of Addiction Psychiatry. These materials and the related activity are not sanctioned by the American Academy of Addiction Psychiatry or any commercial supporters of the conference and do not constitute an official part of that conference.